NCT02533921

Brief Summary

The purpose of this study is to improve outcomes for persons living with Parkinson's Disease (PD) and their family caregivers. The investigators hypothesize that outpatient interdisciplinary palliative care will improve patient-centered outcomes for PD patients at high-risk for poor outcomes.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2015

Longer than P75 for not_applicable

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 27, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
4 months until next milestone

Results Posted

Study results publicly available

January 31, 2020

Completed
Last Updated

January 31, 2020

Status Verified

January 1, 2019

Enrollment Period

3 years

First QC Date

August 20, 2015

Results QC Date

January 10, 2019

Last Update Submit

January 22, 2020

Conditions

Keywords

Palliative CareParkinson's Disease

Outcome Measures

Primary Outcomes (2)

  • Changes in the Subjects Quality of Life (QOL)

    The QOL-AD (Quality of Life in Alzheimer's Disease) survey will be used to measure the differences in the quality of life between groups.Higher numbers indicate better outcomes. The scale ranges from 4 to 52.

    0 to 6 months

  • Changes in Caregiver Distress

    The Zarit Caregiver Burden Interview Form (ZBI) will be used to measure differences in Caregiver Distress between groups. Higher scores indicate worse outcomes. Scale ranges from 0 to 48.

    0 to 6 months

Secondary Outcomes (4)

  • Changes in Patient Anxiety

    0 to 6 months

  • Changes in Patient Depression

    0 to 6 months

  • Changes in Caregiver Anxiety

    0 to 6 months

  • Changes in Caregiver Depression

    0 to 6 months

Study Arms (2)

Standard of Care

OTHER

Usual care as in including both a Primary Care Physician (PCP) and neurologist.

Other: Standard of Care

Interdisciplinary outpatient palliative care

ACTIVE COMPARATOR

Usual care augmented by an outpatient interdisciplinary palliative care team.

Other: Interdisciplinary outpatient palliative care

Interventions

Interdisciplinary outpatient palliative care is an approach to caring for individuals with life-threatening illnesses that addresses potential causes of suffering including physical symptoms such as pain, psychiatric symptoms such as depression, psychosocial issues and spiritual needs. Palliative care approaches have been successfully applied to improve patient-centered outcomes in cancer as well as several chronic progressive illnesses including heart failure and pulmonary disease.

Interdisciplinary outpatient palliative care

Usual care defined as including both a PCP and neurologist

Standard of Care

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Fluent in English
  • UK Brain Bank criteria for diagnosis of probable PD or Multiple Systems Atrophy (MSA) or Corticobasal Degeneration (CBD) or Progressive Supranuclear Palsy (PSP) or Lewy Body Dementia (LBD)
  • At high risk for poor outcomes as identified by the Palliative Care Needs Assessment Tool (PC-NAT)

You may not qualify if:

  • Immediate and urgent palliative care needs
  • Unable or unwilling to commit to study procedures including;
  • randomization,
  • study visits or
  • the addition of a neurologist to their care team
  • Presence of additional chronic medical illnesses which may require palliative services
  • Already receiving palliative care and/or hospice services.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of California, San Francisco

San Francisco, California, 94143, United States

Location

University of Colorado Hospital

Aurora, Colorado, 80045, United States

Location

University of Alberta Canada

Edmonton, Alberta, T6G 2E1, Canada

Location

Related Publications (3)

  • Macchi ZA, Miyasaki J, Katz M, Galifianakis N, Sillau S, Kluger BM. Prevalence and Cumulative Incidence of Caregiver-Reported Aggression in Advanced Parkinson Disease and Related Disorders. Neurol Clin Pract. 2021 Dec;11(6):e826-e833. doi: 10.1212/CPJ.0000000000001110.

  • Koljack CE, Miyasaki J, Prizer LP, Katz M, Galifianakis N, Sillau SH, Kluger BM. Predictors of Spiritual Well-Being in Family Caregivers for Individuals with Parkinson's Disease. J Palliat Med. 2022 Apr;25(4):606-613. doi: 10.1089/jpm.2020.0797. Epub 2021 Nov 24.

  • Kluger BM, Miyasaki J, Katz M, Galifianakis N, Hall K, Pantilat S, Khan R, Friedman C, Cernik W, Goto Y, Long J, Fairclough D, Sillau S, Kutner JS. Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial. JAMA Neurol. 2020 May 1;77(5):551-560. doi: 10.1001/jamaneurol.2019.4992.

MeSH Terms

Conditions

Parkinson Disease

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Results Point of Contact

Title
Benzi Kluger, MD, MS, Principal Investigator
Organization
University of Colorado

Study Officials

  • Benzi Kluger

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2015

First Posted

August 27, 2015

Study Start

October 1, 2015

Primary Completion

September 20, 2018

Study Completion

September 30, 2019

Last Updated

January 31, 2020

Results First Posted

January 31, 2020

Record last verified: 2019-01

Locations